← All organizations

Cassava Sciences

For profit

Also known as: Cassava Sciences | Cassava Sciences, Inc. | Pain Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 26, 2024

Timeline

1990s

Jun 1, 1998
Cassava Sciences— Founded

Drugs by trial phase (6 distinct, 25 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (30)

NCT06390410Lead sponsorPhase 1Jun 26, 2024
NCT06195319Lead sponsorPhase 1Feb 7, 2024
NCT05575076Lead sponsorPhase 3Nov 7, 2022
NCT05575076Study directorPhase 3Nov 7, 2022
NCT05352763Lead sponsorPhase 2May 12, 2022
NCT05026177Lead sponsorPhase 3Nov 30, 2021
NCT05026177Study chairPhase 3Nov 30, 2021
NCT04994483Study chairPhase 3Nov 30, 2021
NCT04994483Lead sponsorPhase 3Nov 30, 2021
NCT04932655Lead sponsorPhase 1May 4, 2021
NCT04388254Study chairPhase 2Mar 16, 2020
NCT04388254Lead sponsorPhase 2Mar 16, 2020
NCT04079803Study directorPhase 2Aug 15, 2019
NCT04079803Lead sponsorPhase 2Aug 15, 2019
NCT03748706Lead sponsorPhase 2Nov 30, 2018

Details

Founded: Austin, TX, US Jun 1, 1998
Last known activity: Jun 26, 2024

Notes

Formerly Pain Therapeutics